Rapid pathway for diagnosing heart attacks does not improve emergency discharge rates
A rapid pathway for diagnosing heart attacks in the emergency department (ED) was as safe as a slower pathway but…
Category: News
Breaking health news, medical updates, policy changes, and public health developments from around the world. We deliver timely, accurate health journalism to keep you informed and aware.
Functional angiography outperforms conventional imaging in AIR-STEMI trial
Functional coronary angiography significantly reduced cardiovascular events and improved safety compared with conventional angiography in patients with ST-segment elevation myocardial…
Digital registry strategy doubles heart failure treatment uptake
A registry-based digital strategy that identified untreated patients and invited them to a telephone consultation more than doubled implementation of an effective type of heart failure treatment. These results…
FDA approves daraxonrasib for patients with metastatic pancreatic cancer
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib for patients whose pancreatic cancer has spread to other parts…
SWITCH SWEDEHEART trial shows prasugrel matches ticagrelor with less bleeding
Prasugrel reduced major cardiovascular events to the same extent as ticagrelor but with lower major bleeding after coronary stenting in…
Trial shows antiplatelet therapy needs personalization after stent implantation
Antiplatelet monotherapy reduced bleeding but dual therapy provided greater cardiovascular event protection in patients at high ischemic risk who had…
Milvexian fails to reduce cardiovascular events after acute coronary syndrome
Milvexian did not reduce major adverse cardiovascular events compared with placebo after a recent acute coronary syndrome and there was…
Trial findings do not support prasugrel monotherapy at the time of primary PCI for STEMI patients
Monotherapy using prasugrel failed to show noninferiority compared with potent antiplatelet therapy plus aspirin at the time of primary percutaneous…
Potent antiplatelet therapy increases bleeding risk after heart attack in AF patients
Potent antiplatelet therapy increased bleeding without signs of benefit regarding cardiovascular events in patients with atrial fibrillation after a heart…
Atorvastatin reduces major cardiovascular events but misses disability-free survival goal
Atorvastatin reduced major cardiovascular events by 30% in older people without known cardiovascular disease, diabetes or dementia, but did not…